CBL-514 Trial Registry: A Study-Reading Checklist
Start with the identifier
The 2026 CBL-514 MRI paper identifies its trial as NCT05736107. That identifier is a more reliable starting point than a headline containing βPhase 2,β because more than one study can share the same phase and compound name.[1]
Our suggested research worksheet starts with a row for the NCT identifier, followed by separate links for the registry, publication and any sponsor update. Keep the publication year separate from the dates when participants were enrolled. A later paper may describe work completed years earlier.
Separate the plan from the results
ClinicalTrials.gov distinguishes estimated enrollment from actual enrollment and provides separate information about study design and posted results.[2] A planned sample size is not a final analysis denominator. Likewise, a scheduled completion date does not establish that the outcome was achieved.
Use three columns in your notes: planned, reported and unresolved. For example, place a registry’s planned imaging endpoint under planned; put the paper’s reported analysis population under reported; leave an unexplained difference under unresolved. Do not silently replace one with the other.
This approach also prevents duplicate counting. A conference abstract, a sponsor announcement and a journal article may all describe the same participants. They are three documents, not necessarily three independent studies.
A practical comparison record
- Study identity: registry number and protocol identifier.
- Research question: anatomical region and named outcome.
- Design: comparator, allocation and masking.
- Population: eligibility, actual enrollment and analyzed count.
- Timing: endpoint visit and document version date.
- Evidence: results table, paper and unresolved differences.
Archive the date of your review. If a record changes, compare versions before interpreting that change. An amendment can be legitimate; what matters is its timing, explanation and effect on the question being answered. This checklist organizes evidence and does not verify the composition of a supplier’s CBL-514 vial.
Frequently asked questions
Does a registered CBL-514 study prove that results are available?
No. Registration describes a study record. Look separately for posted results and a publication, and match both to the same identifier.
Should two papers with the same trial number count twice?
Treat them as potentially overlapping reports until you establish that the participant groups or analyses are independent.
Continue your CBL-514 research
Compare the original study evidence with the documentation for the specific material you are reviewing.
